Jonathan Trollip
Independent Non-Executive Director
Jonathan Trollip, an Independent Non-Executive Director, brings over 30 years of global expertise in commercial, corporate governance, and law. He currently chairs ASX-listed entities, including Global Value Fund Ltd, Plato Income Maximiser Limited, and Spheria Emerging Companies Limited. Jonathan serves as a non-executive director for Kore Potash Limited on LSE, JSE, and ASX. His extensive background includes leadership roles at Meridian International Capital Limited and Herbert Smith Freehills. A Fellow of the Australian Institute of Company Directors, he previously chaired Future Generation Investment Company Ltd, Antipodes Global Investment Company Ltd, and Spicers Limited.
Meet the rest of the team
BCAL is led by a team of experts with deep experience in biotechnology, diagnostics, and healthcare innovation. Our leadership is dedicated to advancing scientific excellence and bringing practical, life-changing solutions to women worldwide.
Shane Ryan
Chief Executive Officer
Kathy Koskiris
Director of Clinical Laboratory Services
Guy Robertson
Chief Financial Officer & Company Secretary
Dr Simon Preston
Director Clinical Research
Alexandra Feetham
Head of Innovation
Kim Kirkham
National Clinical Program Director
Dr Mark David
Director Discovery of Product Development. Senior Clinical Scientist
Dr Klaus-Peter Adam
Director of US Research & Product